Lilly(LLY) - 2025 Q4 - Earnings Call Transcript

Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings call February 04, 2026 10:00 AM ET Company ParticipantsAdrienne Brown - President of Lilly ImmunologyAkash Tewari - Global Head of Biopharmaceutical ResearchDan Skovronsky - Chief Scientific and Product OfficerDave Ricks - Chair and CEOEvan Seigerman - Managing Director and Head of Healthcare ResearchIlya Yuffa - President of Lilly USA and Global Customer CapabilitiesKen Custer - President of Lilly Cardiometabolic HealthLucas Montarce - CFOMichael Yee - Glob ...